Stephen T. Worland - Jun 7, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role: President and Chief Executive, Director
Signature: /s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol: EFTR
Transactions as of: Jun 7, 2022
Transactions value $: $27,400
Form type: 4
Date filed: 6/9/2022, 06:00 AM
Previous filing: May 17, 2022
Next filing: Jun 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFTR	Common Stock	Purchase	$27.4K	+20K	+10.26%	$1.37	215K	Jun 7, 2022	Direct	F1
holding	EFTR	Common Stock						562K	Jun 7, 2022	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.